BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $209,000 | -10.3% | 180,000 | 0.0% | 0.00% | – |
| Q4 2015 | $233,000 | 0.0% | 180,000 | 0.0% | 0.00% | – |
| Q3 2015 | $233,000 | -16.2% | 180,000 | 0.0% | 0.00% | – |
| Q2 2015 | $278,000 | -33.5% | 180,000 | -35.7% | 0.00% | -100.0% |
| Q1 2015 | $418,000 | -35.6% | 280,000 | -49.1% | 0.00% | 0.0% |
| Q4 2014 | $649,000 | – | 550,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ferox Capital Management LP | 5,000,000 | $5,356,000 | 2.91% |
| Lombard Odier Asset Management (Europe) Ltd | 31,900,000 | $34,087,000 | 2.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 15,970,000 | $16,929,000 | 1.92% |
| MACKAY SHIELDS LLC | 24,283,000 | $25,802,000 | 1.34% |
| Verition Fund Management LLC | 7,982,000 | $8,491,000 | 1.20% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 62,750,000 | $66,638,000 | 1.03% |
| OAKTREE CAPITAL MANAGEMENT LP | 34,510,000 | $37,002,000 | 0.61% |
| Jabre Capital Partners S.A. | 3,500,000 | $3,722,000 | 0.32% |
| Calamos Wealth Management LLC | 656,000 | $695,000 | 0.20% |
| Baker Brothers Advisors | 12,500,000 | $13,203,000 | 0.17% |